A Real-World Comparison of First-Line Regimens in Transplant Ineligible Patients with Multiple Myeloma

被引：0
|
作者：
Abdallah, Nadine [1 ]
Chakraborty, Rajshekhar [2 ]
Visram, Alissa [3 ]
Gayowsky, Anastasia [4 ]
Pond, Gregory [5 ]
Seow, Hsien [5 ]
Kumar, Shaji [1 ]
Mian, Hira [5 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Columbia Univ, Med Ctr, New York, NY USA
[3] Univ Ottawa, Ottawa, ON, Canada
[4] Inst Evaluat Sci, Hamilton, ON, Canada
[5] McMaster Univ, Hamilton, ON, Canada
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-318
引用
收藏
页码：S217 / S218
页数：2
相关论文
共 50 条
  • [1] Network meta-analysis of first-line treatments in transplant-ineligible multiple myeloma patients
    Gil-Sierra, Manuel David
    Gimeno-Ballester, Vicente
    Fenix-Caballero, Silvia
    Alegre-Del Rey, Emilio Jesus
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 105 (01) : 56 - 65
  • [2] Treatment patterns and outcomes in real-world transplant-ineligible patients newly diagnosed with multiple myeloma
    María José Cejalvo
    Gabriela Bustamante
    Esther González
    Judith Vázquez-Álvarez
    Ricarda García
    Ángel Ramírez-Payer
    Ernesto Pérez-Persona
    Eugenia Abella
    Sebastián Garzón
    Antoni García
    Isidro Jarque
    Marta Sonia González
    Antonia Sampol
    Cristina Motlló
    Josep María Martí
    Magdalena Alcalá
    Rafael Duro
    Yolanda González
    José Luis Sastre
    Josep Sarrà
    Giselle Lostaunau
    Rocío López
    Javier de la Rubia
    Annals of Hematology, 2021, 100 : 1769 - 1778
  • [3] Treatment patterns and outcomes in real-world transplant-ineligible patients newly diagnosed with multiple myeloma
    Cejalvo, Maria Jose
    Bustamante, Gabriela
    Gonzalez, Esther
    Vazquez-Alvarez, Judith
    Garcia, Ricarda
    Ramirez-Payer, Angel
    Perez-Persona, Ernesto
    Abella, Eugenia
    Garzon, Sebastian
    Garcia, Antoni
    Jarque, Isidro
    Gonzalez, Marta Sonia
    Sampol, Antonia
    Motllo, Cristina
    Marti, Josep Maria
    Alcala, Magdalena
    Duro, Rafael
    Gonzalez, Yolanda
    Sastre, Jose Luis
    Sarra, Josep
    Lostaunau, Giselle
    Lopez, Rocio
    de la Rubia, Javier
    ANNALS OF HEMATOLOGY, 2021, 100 (07) : 1769 - 1778
  • [4] The Role of Monoclonal Antibodies in the First-Line Treatment of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma
    Bonello, Francesca
    Grasso, Mariella
    D'Agostino, Mattia
    Celeghini, Ivana
    Castellino, Alessia
    Boccadoro, Mario
    Bringhen, Sara
    PHARMACEUTICALS, 2021, 14 (01) : 1 - 14
  • [5] MODELLING FIRST-LINE DARATUMUMAB USE IN NEWLYDIAGNOSED, TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA IN SINGAPORE
    Bayani, D. B.
    Nagarajan, C.
    Tso, A. C. Y.
    Ooi, M.
    Wee, H. L.
    VALUE IN HEALTH, 2023, 26 (06) : S86 - S87
  • [6] Safety Profile for Lenalidomide-Based and Non-Lenalidomide-Based First-Line Therapy for Multiple Myeloma in Transplant Ineligible Patients: Real-World Evidence from a European PostAuthorization Safety Study
    Cavo, Michele
    De Stefano, Valerio
    Payer, Angel Ramirez
    Wiesholzer, Martin
    Tromp, Yvonne
    Vanstraelen, Gaetan
    Schaedlich, Baerbel
    Valentine, Richez
    Dhanasiri, Sujith
    Kueenburg, Elisabeth
    Rosettani, Barbara
    Martin, Claire
    Pozzi, Stefano
    Bacon, Pamela
    Gamberi, Barbara
    BLOOD, 2019, 134
  • [7] Survival, health care resource utilization and expenditures of first-line treatments for multiple myeloma patients ineligible for transplant in Taiwan
    Cheng, Chih-Ning
    Huang, Shang-Yi
    Lien, Pei-Wen
    Huang, Shih-Ting
    Lin, Fang-Ju
    PLOS ONE, 2021, 16 (05):
  • [8] First-Line Daratumumab-Based Regimens in Multiple Myeloma Patients Aged 65-70 Years: A Pilot Real-World Study on Efficacy and Safety
    Palmieri, Salvatore
    Della Pepa, Roberta
    Rocco, Stefano
    Reina, Raffaella
    Gaeta, Giuseppe
    Pugliese, Novella
    Leone, Aldo
    Trastulli, Fabio
    Gravetti, Angela
    Celentano, Maria
    Pedata, Mariangela
    Grimaldi, Francesco
    Pane, Fabrizio
    Annunziata, Mario
    BLOOD, 2024, 144 : 7073 - 7074
  • [9] FIRST-LINE THERAPY FOR PATIENTS WITH MULTIPLE MYELOMA: DIRECT AND INDIRECT COMPARISON OF TREATMENT REGIMENS ON THE EXISTING MARKET
    Kuhr, K.
    Wirth, D.
    Srivastava, K.
    Lehmacher, W.
    Hellmich, M.
    VALUE IN HEALTH, 2014, 17 (07) : A617 - A617
  • [10] First-line CyborD treatment for graft ineligible multiple myeloma patients: Real-life efficacy and tolerability.
    Duquette, Dominic
    Germain, Marie-Michelle
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345